CED Announces Confirmed Pharma and Investor Attendees for 2011 Biotech/Life Science Conference

North Carolina Governor Beverly Perdue to provide opening remarks

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- CED, the southeast’s largest entrepreneurial support organization, today announced North Carolina Governor Beverly Perdue is scheduled to provide opening remarks at its 20th annual Biotech/Life Science Conference. The two-day event, hosted in partnership with the North Carolina Biotechnology Center and NCBIO, is being held February 21-22, 2011, at the Raleigh Convention Center. Currently tracking ahead of 2010 registration numbers, attendees from nearly 50 pharmaceutical companies and investor funds are registered to participate.

The conference has grown exponentially since its inception in 1991. In 2010, the event drew 56 unique venture capital funds of 100 investors, including 43 from outside North Carolina. To date, 65 unique venture capital funds are confirmed to attend this year’s GlaxoSmithKline’s Venture Day.

“The conference brings together a unique combination of executives from early stage companies as well as veteran industry players and investors – all of whom share the same goal of driving innovation in life sciences, healthcare, medtech and pharmaceuticals,” said Ed Mathers, a partner at venture capital firm, New Enterprise Associates. “This year’s event provides the best platform for those seeking to transform ideas into action.”

To date, confirmed investor funds attending the conference include:

  • 5am Ventures
  • Accelerator
  • Apposite Capital LLP
  • Atlas Ventures
  • Bay City Capital
  • Cardinal Partners
  • CHL Medical Partners
  • CMEA Ventures
  • Flagship Ventures
  • Follica, Inc.
  • Forward Ventures
  • Hatteras Venture Partners
  • Healthcap
  • Index Ventures
  • Intersouth Partners
  • L Capital Partners
  • Life Sciences Partners
  • Lilly Ventures
  • MVM Capital
  • NEA
  • NewSpring Capital
  • Pappas Ventures
  • Phoenix IP Ventures
  • Polaris Venture Partners
  • Prospect Venture Partners
  • Quaker BioVentures
  • Red Abbey Venture Partners
  • RiverVest
  • Safeguard Scientifics
  • Skyline Ventures
  • Sofinnova Ventures
  • Third Rock Ventures
  • TPG Growth, LLC
  • Triathlon Medical Ventures
  • Versant Ventures
  • Vivo Ventures
  • Warburg Pincus LLC

To date, confirmed pharmaceutical companies attending the conference include:

  • AstraZeneca
  • Celgene
  • GlaxoSmithKline
  • MedImmune
  • Merck
  • Novo Nordisk
  • Pfizer
  • Targacept
  • United Therapeutics Corporation

“While we work to develop innovative therapies, it’s important to remain on the forefront of new technologies and continuously look for ways to add to and improve our R&D pipeline,” said Sanjeev Munshi, Ph.D, MBA, director, licensing and external research, southeastern U.S., Merck & Co. Inc. “This conference gives us the opportunity to meet with organizations developing novel approaches to meet unmet medical needs.”

To register for the 2011 Biotech/Life Science Conference, visit http://bit.ly/gFUf9y.

About CED

CED, the southeast’s largest entrepreneurial support organization, connects emerging growth companies with the necessary tools and resources to start something new. A private, non-profit organization, CED harnesses its broad network to support companies that want to take their business to the next level. As the oldest entrepreneurial network in the country, CED has enabled entrepreneurs to raise more than one billion dollars in capital, launched more than 700 companies and currently serves more than 5,500 active members representing nearly 1,100 companies in North Carolina.


for CED
Kristi Lee John, 919-821-2822
[email protected]

KEYWORDS:   United States  North America  North Carolina

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Pharmaceutical